Press Releases

Featured Press Releases

BIO Statement on Passage of Legislation…

WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…

Learn more

Announcing Investor Connect Plus: A LaunchBio x…

Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…

Learn more

BIO Statement on Reintroduction of the PASTEUR Act

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …

Learn more

BIO Statement on House Passage of Mikaela Naylon Give Kids a Chance Act

December 1, 2025

WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…

BIO Statement on Most Favored Nation

September 30, 2025

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…

BIO Statement on Industry Tariffs

September 26, 2025

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…

BIO Extends Agreement with Avantor for Five Additional Years.

September 17, 2025

Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…

BIO Statement on Passage of the Reconciliation Package

July 3, 2025

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA):“The OBBBA contains important bipartisan provisions…

Massachusetts Governor Maura Healey Named BIO’s Governor of the Year

June 17, 2025

Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…

BIO Elects Genentech’s Fritz Bittenbender as New Board Chair

June 16, 2025

Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…

BIO International Convention Opens in Boston, Showcasing Global Innovation in Biotechnology

June 16, 2025

The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanityBOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for…

BIO Statement on HHS Dismissal of CDC Advisory Committee Members

June 9, 2025

WASHINGTON, D.C. - John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding today’s dismissal of the voting members of the CDC Advisory Committee on Immunization Practices: …

BIO Announces Dedicated Focus on Human Health and Biopharmaceutical Innovation

May 28, 2025

BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth  Washington, DC, May 28, 2025 – The Biotechnology Innovation…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.